Discontinuation report MYLAN-SERTRALINE

Last updated on 2018-03-02 History
Report ID 20295
Drug Identification Number 02242520
Brand name MYLAN-SERTRALINE
Common or Proper name SERTRALINE
Company Name MYLAN PHARMACEUTICALS ULC
Market Status CANCELLED POST MARKET
Active Ingredient(s) SERTRALINE
Strength(s) 50MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 100BT, 500BT
ATC code N06AB
ATC description ANTIDEPRESSANTS
Reason for discontinuation Business reasons
Anticipated discontinuation date 2018-03-01
Actual discontinuation date 2018-03-01
Remaining supply date 2018-03-01
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments Discontinued in shortage ID 5979. Last lot 3041741 Expires 31-May-18
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2017-08-24 English Compare
v2 2017-08-24 French Compare
v3 2017-10-23 English Compare
v4 2017-10-23 French Compare
v5 2017-12-20 English Compare
v6 2017-12-20 French Compare
v7 2018-03-01 English Compare
v8 2018-03-01 French Compare
v9 2018-03-02 English Compare

Showing 1 to 9 of 9